Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual buprenorphine versus intravenous morphine for primary headache in the emergency department
IRCT2015030821379N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of buprenorphine and morphine in Primary headache disorder (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Pain relief. Started Mar 2015; status: completed.
02
Drugs
buprenorphinemorphine
03
Conditions
Primary headache disorder
Beyond the preview
Go deeper on IRCT2015030821379N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015030821379N1.